Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

March 02, 2026 08:00 ET | Source: Elutia Inc.

Elutia Selects Pete Ligotti as CCO to Lead the Commercial Launch of NXT-41x and Transform Post-Mastectomy Care in the $1.5B U.S. Breast Surgery Market

Elutia Selects Pete Ligotti as CCO to Lead the Commercial Launch of NXT-41x and Transform Post-Mastectomy Care in the $1.5B U.S. Breast Surgery Market
February 24, 2026 10:28 ET | Source: Smith & Nephew UK Ltd

Smith+Nephew signs exclusive US distribution agreement with RMR Ortho for patented technology that provides a unique dynamic compression nitinol fixation option (A'TOMIC™) to our surgeons

Smith+Nephew announces it has signed an exclusive US distribution agreement with RMR Ortho
February 23, 2026 16:30 ET | Source: Smith & Nephew UK Ltd

Smith+Nephew signs distribution agreement with SI-BONE

Smith+Nephew today announced it has signed a distribution agreement with SI-BONE, focused on their innovative iFuse TORQ portfolio.
February 19, 2026 10:58 ET | Source: Mordor Intelligence

Wound Dressings Market - 65% Share for Advanced Dressing in 2025 as Europe Set to Record 4.51% CAGR Through 2031, Reports Mordor Intelligence

Hyderabad, India, Feb. 19, 2026 (GLOBE NEWSWIRE) -- According to Mordor Intelligence, the wound dressings market size is valued at USD 5.42 billion in 2026 and is projected to reach USD 6.47 billion...
February 18, 2026 04:00 ET | Source: SNS Insider pvt ltd

Scar Treatment Market Size is Expected to Reach USD 56.30 Billion by 2033; Growth is Propelling Due to the Surging Awareness for Advanced Cosmetic and Reconstructive Procedures Globally

Scar Treatment Market to reach USD 56.30 Billion by 2033 at 9.91% CAGR, driven by rising acne, surgical scars, laser innovation, and strong APAC growth.
February 17, 2026 01:15 ET | Source: Basilea Pharmaceutica International Ltd, Allschwil

Basilea erzielt starke Ergebnisse im Geschäftsjahr 2025 und übertrifft Umsatz- und Betriebsgewinn-Guidance

15 % Anstieg der Lizenzeinnahmen 11 % Anstieg der GesamtumsätzeNettoliquidität verdreifacht Phase-3-Programm mit Fosmanogepix verläuft wie geplantGesamtumsatz und Betriebsgewinn 2026: zweistelliges...
February 17, 2026 01:15 ET | Source: Basilea Pharmaceutica International Ltd, Allschwil

Basilea reports strong 2025 full-year results, surpassing revenue and operating profit guidance

15% royalty income increase 11% total revenue increaseTripled net cash position Phase 3 program with fosmanogepix progressing as plannedFinancial guidance FY 2026: Double-digit increase in total...
February 13, 2026 04:06 ET | Source: Research and Markets

1 Day Regulations & Operational Compliance for Funds Training Course: Transfer Agency, Fund Accounting, Pricing Risk, Governance & COLL Compliance Essentials (ONLINE EVENT: March 17th, 2026)

Dublin, Feb. 13, 2026 (GLOBE NEWSWIRE) -- The "Regulations & Operational Compliance for Funds (Mar 17th, 2026)" training has been added to ResearchAndMarkets.com's offering.The course is...
February 12, 2026 10:00 ET | Source: Lone Wolf Technologies

Lone Wolf Technologies Announces 2026 PropTech Advisory Board

DALLAS, Feb. 12, 2026 (GLOBE NEWSWIRE) -- Lone Wolf Technologies, the trusted leader in real estate software, today announced the members of its 2026 PropTech Advisory Board, bringing together some...
February 11, 2026 02:00 ET | Source: Reset Health

Reset Health Further Strengthens Advisory Board With Appointment of Pinder Sahota

LONDON, Feb. 11, 2026 (GLOBE NEWSWIRE) -- Reset Health (“the Company”), the experts in the personalised management of chronic disease, today announces Pinder Sahota has joined the Company as a...